Balasa Dinverno & Foltz LLC Edwards Lifesciences Corp Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 6,641 shares of EW stock, worth $500,598. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,641

Previous 6,944 4.36%

Holding current value

$500,598

Previous $660,000 16.82%

% of portfolio

0.03%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$82.37 - $107.29 $24,958 - $32,508	-303 Reduced 4.36%	6,641 $549,000
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $4,930 - $7,311	-57 Reduced 0.81%	6,944 $660,000
Q1 2022 Apr 25, 2022	BUY	$101.96 - $128.34 $71,983 - $90,608	706 Added 11.22%	7,001 $824,000
Q4 2021 Jan 26, 2022	BUY	$106.37 - $130.68 $12,551 - $15,420	118 Added 1.91%	6,295 $816,000
Q3 2021 Oct 26, 2021	BUY	$102.91 - $122.75 $135,841 - $162,030	1,320 Added 27.18%	6,177 $699,000
Q2 2021 Jul 23, 2021	BUY	$83.84 - $104.76 $8,467 - $10,580	101 Added 2.12%	4,857 $503,000
Q1 2021 Apr 29, 2021	SELL	$78.68 - $90.67 $5,428 - $6,256	-69 Reduced 1.43%	4,756 $398,000
Q4 2020 Jan 26, 2021	BUY	$71.69 - $91.23 $2,007 - $2,554	28 Added 0.58%	4,825 $440,000
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $11,489 - $14,952	-171 Reduced 3.44%	4,797 $383,000
Q2 2020 Aug 07, 2020	SELL	$57.54 - $76.95 $32,567 - $43,553	-566 Reduced 10.23%	4,968 $343,000
Q1 2020 Apr 30, 2020	SELL	$52.41 - $81.0 $24,161 - $37,341	-461 Reduced 7.69%	5,534 $1.04 Million
Q4 2019 Jan 22, 2020	BUY	$71.7 - $82.09 $12,045 - $13,791	168 Added 2.88%	5,995 $1.4 Million
Q3 2019 Nov 06, 2019	BUY	$61.55 - $75.43 $15,079 - $18,480	245 Added 4.39%	5,827 $1.28 Million
Q2 2019 Aug 07, 2019	SELL	$55.74 - $64.41 $55 - $64	-1 Reduced 0.02%	5,582 $1.03 Million
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $8,955 - $11,977	187 Added 3.47%	5,583 $1.07 Million
Q4 2018 Feb 04, 2019	SELL	$46.41 - $56.94 $29,563 - $36,270	-637 Reduced 10.56%	5,396 $827,000
Q2 2018 Aug 01, 2018	SELL	$42.45 - $51.3 $1,825 - $2,205	-43 Reduced 0.71%	6,033 $878,000
Q4 2017 Feb 05, 2018	SELL	$33.79 - $39.39 $3,379 - $3,939	-100 Reduced 1.62%	6,076 $685,000
Q3 2017 Oct 18, 2017	BUY	$36.29 - $38.83 $224,127 - $239,814	6,176	6,176 $675,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Edwards Lifesciences Corp Transaction History